Ovarian Cancer Midwest Focus


The 2019 Ovarian Cancer Midwest Focus Conference will focus on basic science, translational and clinical topics on ovarian cancer and will offer sessions on emerging topics such as cancer metabolism, novel therapeutics and personalized medicine. 

Monday, November 4, 2019 ***TENTATIVE AGENDA***

1:00 - 3:00 pm: Early Detection

"Searching for needles in a haystack: Identification of early stage ovarian cancer protein biomarkers in a multiplex platform." - Amy Skubitz, PhD

"Clinical Applications/cases/future directions." - Andrew Godwin, PhD

3:00 - 5:00 pm: Immunotherapy

"Maximizing Natural Killer cell mediated immunotherapy in ovarian cancer via cytokine stimulation and checkpoint blockade." - Martin Felices, PhD

"Expression of recombinant Fc receptors by engineered lymphocytes for targeting diverse tumor antigens." - Bruce Walcheck, PhD

"Clinical applications/cases/future directions." - Melissa Geller, MD

Tuesday, November 5, 2019 ***TENTATIVE AGENDA***

8:00 - 10:00 am: Novel Therapeutics

"Dozens of new cancer drugs do little to improve survival." - Ilana Chefetz, PhD

"Microtubules stability and chemoresistance: Therapeutic Implications." - Martina Bazzaro, PhD

"Clinical applications/cases/future directions." - William F. Bradley, MD

10:00 - 12:00 pm: Metabolism

"Overview on ovarian cancer metabolism." - Xiaonan Zhang, PhD, Visiting Researcher UMN

"Oxidative Phosphorylation: A target for therapeutic strategies." - Ilana Chefetz, PhD

12:00 pm: Lunch + Panel Discussion with Patients

1:00 - 3:00 pm: Preclinical Modes of Ovarian Cancer

"Progesterone preceptor signaling drives DREAM-meditated quiescence and cancer cell phenotypes in models of early HGSC." - Laura Mauro, PhD

"Tracking Progesterone Receptor Actions in Breast Cancer Progression to Endocrine Resistance." - Carol Lange, PhD

"Ovarian and fallopian tube communication in high grade serous ovarian cancer." -Joanna Burdette, PhD

"Ovarian cancer PDX Models in Preclinical and Clinical Studies." - John Weroha, MD, PhD

3:00 - 5:00 pm: Personalized Medicine

"Probing the molecular genetics of ovarian cancer at the single cell level." - Tim Starr, PhD

"Where We Need to be in 10 Years: A Challenge for the Decade Ahead." - Scott Kaufmann, MD, PhD